More Diagnostics, a trusted leader in in vitro diagnostic quality controls for over 30 years, is proud to announce the debut of two advanced cardiac-focused products: a High-Sensitivity Troponin ...

PLEASANT GROVE, Utah, Jan. 29, 2026 /PRNewswire/ -- Renew Biotechnologies (Renew) today announced its role as the clinical testing provider for Path Fertility's NOA Guide, a newly launched epigenetic ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the ...

Validation Data on More Than 100 Patients published in Journal of Molecular Diagnostics CHICAGO, April 25, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the ...

HOUSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...

Quest Diagnostics, a diagnostic information services provider, and Inovalon, a cloud-based data analytics provider, have partnered to launch Data Diagnostics. Data Diagnostics is a suite of hundreds ...

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the instrumentation industry in ...

Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in ...

Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. PrecisionCHD is a clinical blood test that can detect CHD at a ...